Medicure (OTCMKTS:MCUJF) Shares Pass Below 200-Day Moving Average – Should You Sell?

Medicure Inc. (OTCMKTS:MCUJF)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.83 and traded as low as $0.8164. Medicure shares last traded at $0.8164, with a volume of 125 shares.

Medicure Price Performance

The company has a market cap of $8.52 million, a P/E ratio of -1.74 and a beta of 0.98. The company has a fifty day moving average price of $0.83 and a two-hundred day moving average price of $0.83. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 1.04.

Medicure (OTCMKTS:MCUJF) last released its earnings results on Thursday, May 21st. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.01. Medicure had a negative return on equity of 44.34% and a negative net margin of 21.65%.The business had revenue of $5.79 million for the quarter, compared to analyst estimates of $3.63 million.

About Medicure

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.